Introduction
Angiogenesis is involved in the response of the organism to ischemic injury, and contributes to tissue revascularization and organ preservation [1] . During angiogenic processes, endothelial cells (ECs) are exposed to several pro-and anti-angiogenic factors that control the triggering of signals for cells to degrade the bordering matrix and expand until new blood vessels are formed.
There is increasing evidence that the initiation of neovascularization in the setting of tissue ischemia is related to the recruitment and activation of monocytes/macrophages within the ischemic tissues [2, 3] . Monocytes (Mo) are recruited from circulation to the damaged tissue by the local production of cytokines and chemokines [4] . Recruited Mo stimulate EC proliferation, differentiation, migration and organization in tubular networks, all in a tightly regulated angiogenic factor-rich environment [5, 6] .
Recruited Mo may induce neovascularization by releasing proangiogenic mediators but also by transdifferentiation into endothelial cell-like (ECL) cells. Recruited Mo do not seem to form vascular networks; rather, they phenotypically mimic ECs [7] . It has been reported that Mo can acquire endothelial features under angiogenic stimulation: they can develop an endothelial-like phenotype positive for specific surface vascular endothelial markers [7] and even form capillary-like structures [8] , suggesting that they could participate in neovascularization in close relationship with ECs. However, the angiogenic factors responsible for Mo to ECL transformation are not known.
Recently, we have demonstrated that Mo participate in angiogenic processes by releasing Wnt5a, which interacts with FZD5 in microvascular ECs (mECs), and through the non-canonical pathway increases intracellular Ca 2+ release and NF-jB activation that upregulates tissue factor (TF) expression and induces angiogenesis [6] . TF is the essential initiator of blood coagulation. In addition to its roles in the coagulation cascade, TF has non-hemostatic functions as a multi-faceted signaling receptor involved in the regulation of angiogenesis [9, 10] . TF naturally occurs in two different variants: full-length TF (flTF) and alternatively spliced TF (asTF). flTF is a~45 = 47 kDa integral membrane protein that can be released from the cell membrane in the form of microvesicles, whereas asTF is a protein that lacks a transmembrane domain and can thus be secreted in a soluble form. Both forms constitute a pool of circulating TF that has been associated with monocyte-endothelial interactions and angiogenic processes [11] [12] [13] .
Because TF plays an important role in angiogenesis and it has been closely linked with monocyte-endothelial cell interactions, we examined whether TF might exert angiogenic effects by promoting mobilization and transdifferentiation of Mo into ECL cells.
Materials and methods

Endothelial cell cultures
Immortalized human microvascular endothelial cell line (HMEC-1) [14] from the Center for Disease Control (Atlanta, GA, USA) was routinely maintained as described in Arderiu et al. [15] . Key experiments were repeated with primary cultures of human dermal microvascular endothelial cells (HDMEC).
Isolation of monocytes
Isolation of human peripheral blood mononuclear cells (PBMC) was performed by gradient centrifugation of buffy coats from healthy donors over Ficoll-Paque Plus (GE Healthcare, Barcelona, Spain). PBMC were subsequently collected and washed in phosphate buffered saline (PBS) four times. Total Mo and Mo subsets were isolated from the PBMC fraction using magnetic bead sorting.
CD14
+ cells from PBMC were enriched with a beadlabeled anti-CD14 monoclonal antibody (Miltenyi Biotech, Barcelona, Spain) using the magnetic antibody cell sorting (MACS) system (Miltenyi Biotech). The purity of CD14 + Mo was found routinely to be more than 90% as judged by flow cytometry analysis using a PerCP-conjugated mouse monoclonal anti-human-CD14 (Immunostep, Salamanca, Spain). For each sample, at least 10 000 events were acquired on a Coulter Epics XL Flow Cytometer equipped with a 488-nm argon laser (Beckman Coulter, Barcelona, Spain). Samples incubated with the same final concentration of isotype-matched antibody were used as negative controls. The data were analyzed using the Expo32 program (Beckman Coulter). For CD16 + we used a CD16 + Isolation Kit (Miltenyi Biotech) following the manufacturer's instructions. The purity of the CD16 + Mo subset obtained was examined by flow cytometry with fluorescein isothiocyanate (FITC)-conjugated anti-human CD16 antibody (purity ≥ 97%) (Fig. S1 ).
Cells were usually seeded on surface-modified polystyrene dishes for enhanced cell attachment (BD Falcon; BD Bioscience, Madrid, Spain) and cultured in RPMI 1640 (Gibco, Thermo Fisher Scientific, Barcelona, Spain) supplemented with 10% human serum A/B and 1% penicillin/streptomycin. After 2-4 h, cultures were washed in PBS four times to remove non-attached cells and fresh medium was added.
Overexpression of flTF and asTF in mECs
The generation of lentivirus expressing flTF has previously been described in detail in Arderiu et al. [15] . HMEC-1 was infected with pLVx-flTF to establish the flTF-overexpressing line flTF + mECs. asTF cDNA from Dr Bogdanov's laboratory was cloned in pLVX vector (Clontech Laboratories Inc., Takara Bio Europe, SaintGermain-en-Laye, France) at XhoI/ApaI restriction sites. pLVx-asTF was also used to overexpress asTF in HMEC-1 and to obtain the asTF-overexpressing line asTF + mECs. Lentiviral vectors were transduced into HMEC-1 as described in Arderiu et al. [15] .
Silencing TF
Delivery of small interfering RNAs (siRNAs) into HMEC-1 was carried out with a Nucleofector device and its corresponding kits (Amaxa, Inc., Lonza, Barcelona, Spain). The scrambled siRNA or annealed pre-designed siRNA against TF (s4932) were purchased from Applied Biosystems (Thermo Fisher Scientific).
Conditioned medium collection
Mo-conditioned medium (CM) was collected after 24 h of Mo cultures, spun at 287 9 g for 10 min and used immediately. CM obtained from HMEC-1 transfected with empty vectors (mECs-CM) or flTF expressing vector (flTF + mECs-CM) or asTF expressing vector (asTF + mECs-CM) was collected from exponentially growing cells cultured in EGM-2 (Lonza) for 48 h and spun at 127 9 g for 5 min and used immediately.
Analysis of TF-rich microvesicles in cell culture medium Microvesicle concentration was determined using the Zymuphen microparticle determination kit (Hyphen BioMed, West Chester, OH, USA) and flow cytometry as described in Arderiu et al. [16] .
Real-time RT-PCR
Total RNA from cultures was isolated using the RNeasy isolation kit (Qiagen, Barcelona, Spain) according to the manufacturer's instructions. Reverse transcription was performed with the High Capacity cDNA Archive Kit (Applied Biosystems) with random primers. Assayson-Demand ™ (Applied Biosystems) of TaqMan ™ fluorescent real-time PCR primers were used for TF (Hs00175225_m1), b1-integrin (Hs00559595_m1) and GAPDH (Glyceraldehyde 3-phosphate dehydrogenase) (4326317E) as endogenous control. asTF-and flTF-specific forward-reverse primer pairs and TaqMan probes were purchased from IDT (Leuven, Belgium) [17] .
Western blot analysis
Protein preparations (25 lg) were resolved on 10% SDS-PAGE gels and transferred onto nitrocellulose membranes. After blocking non-specific binding, membranes were incubated with: a polyclonal anti-TF antibody (American Diagnostica, Sekisui Diagnostics GmbH, Pfungstadt, Germany, #4501, dilution 1 : 1000); a rabbit monoclonal anti-asTF antibody from Dr Bogdanov's laboratory; monoclonal anti-b1-integrin antibody [CD29] (Millipore, Madrid, Spain, #EP1041Y,dilution 1 : 500) followed by rabbit anti-goat-HPR (1 : 10 000), rabbit anti-mouse-HPR (1 : 10 000) or goat anti-rabbit-HPR (1 : 10 000). Band densities were analyzed on a ChemiDoc XRS ™ system (Bio-Rad, Barcelona, Spain) using chemiluminescence detection mode and Quantity-One software (Bio-Rad). 
Cell proliferation
Cells were stained with 20 lg mL À1 propidium iodide containing 20 lg mL À1 RNase A and then analyzed in an EPICS XL flow cytometer (Beckman Coulter). The percentages of cells in the G1, S and G2-M phases were determined using Modfit LT 3.2 software (Verity Software house, Topsham, ME, USA).
Immunocytochemistry
Endothelial cell-like cells cultured in 3DBM were fixed in 4% paraformaldehyde solution and prepared for immunostaining as described [18] . We used as primary antibody a rabbit anti-human-VWF 
Results
CD16
+ Mo subset can be expanded by TF Several cytokines have been reported to induce the expression of CD16 + in human monocytes both in vitro and in vivo [19] . In previous studies, we demonstrated that Mo induce angiogenesis by stimulating TF expression in mECs [6] . A highly significant induction of flTF and asTF mRNA (at 2 h) and protein expression (at 24 h) has been detected in HMEC-1 cultured with Mo-conditioned media (Mo-CM of 24 h) ( Fig. 1A and B). TF may be released to the media in the form of microvesicles, as well as in soluble form as asTF. Our results show that both isoforms of TF were secreted to the media after 24 h of culture with Mo-CM (Fig. 1B) . Moreover, TF-containing microvesicles could be visualized by flow cytometry with a monoclonal anti-TF antibody (Fig. 1C ). Results were similar for primary HDMECs and the stable cell line HMEC-1 ( Fig. S2A and B) ; therefore, we performed the next experiments in HMEC-1 because no stable transfection could be obtained using HDMECs.
Next, we studied whether TF secreted by HMEC-1 would induce conversion of CD16 À Mo into CD16 + Mo. For this purpose, HMEC-1 were stably transfected with empty vector (mECs) or with vectors encoding for flTF (flTF + mECs) or asTF (asTF + mECs). Stable clones were selected using puromycin and analyzed using RT-PCR and immunoblot to confirm flTF or asTF expression ( Fig. S2C and D) . This allowed for the independent analysis of biological effects of each TF isoform.
Mo were cultured with mECs-conditioned media (CM), flTF + mECs-CM or asTF + mECs-CM for 24 h and CD16 + expression was analyzed by flow cytometry. As shown in Fig. 2(A) , the number of CD16 + Mo was increased by mECs-CM compared with endothelial media (fresh EGM-2). Results also showed that the number of CD16 + Mo was significantly increased when Mo were cultured with CM containing high levels of flTF or asTF ( Fig. 2A) . Similar results were obtained when Mo were stimulated with recombinant human (rh)-TF (100 pM, ProSpec-Tany TechnoGene Ltd, Rehovot, Israel), but not with other cytokines such as rh-CCL2 (50 ng mL À1 , Sigma-Aldrich) or TNF-a (50 ng mL À1 , Sigma-Aldrich)
that are known to be present in endothelial cell secretome. In order to corroborate that CD16 + Mo expansion was TF dependent, we silenced TF in HMEC-1 and we used their CM ( Fig. S2C-E) . The annealed pre-designed TF siRNA silenced the expression of flTF and asTF. Alternative splicing eliminates exon 5 from TF mRNA and we thus used a TF siRNA with a sequence 5 0 ggacuuaauuuauacacuutt3 0 , which is located in exon 4. We used specific primers that amplify flTF and asTF separately [17] to confirm TF silencing (Fig. S2C) . In all experiments, scrambled siRNA control (AM4635) was used to evidence unspecific changes in the gene expression profile or in the cell phenotype. Results showed that expansion of CD16 + Mo was highly reduced when TF isoforms were absent in CM (3.08 AE 1.25% vs. 19.5 AE 0.35%, P < 0.001) (Fig. 2B ). In addition, the antibody against flTF (10H10) inhibited the increased CD14 + CD16 + Mo differentiation induced by TF-rich CM (5.25 AE 39 vs. 38.53 AE 2.5, P < 0.001) (Fig. 2B) . These results show that the effect observed in differentiation of Mo into CD16 + Mo was TF dependent; moreover, as shown in Fig. 2(C) , the effect of TF on the differentiation of CD16 + Mo was dose dependent. In summary, Mo exposed to endothelial cell-derived TF differentiate into CD16 + phenotype.
TF induces transdifferentiation of Mo into functional ECs
Mo can express vascular endothelial cell (VEC) markers under angiogenic stimulation from the first week in culture transdifferentiating into ECL cells [7] . Here, we tested whether TF released by mEC could induce Mo transdifferentiation into ECL cells. CD16 + Mo were obtained from PBMCs isolated from healthy donors. Isolated Mo were cultured on fibronectin-coated plastic dishes and then treated with mECs-CM, flTF + mECs-CM or asTF + mECs-CM. Figure 3(A) shows that from the third day in culture, the majority of cells were attached and their morphology was changing, especially in the presence of TF (flTF and asTF). Cells began to form colonies (arrows) with cobblestone phenotype and gradually became spindle shaped (Fig. 3A and Figure S3A ). After 8-10 days in culture, we detected a large number of spindle-shaped cells in TF-exposed cells. In order to prove that TF was responsible for these phenotype changes, CD16 + Mo were cultured with CM obtained from mECs transfected with TF siRNA (siTFmECs-CM) and compared with CM from mECs transfected with On non-coated dishes or when cultured with RPMI media, the cells only rarely changed their morphology to the spindle-like form ( Figure S3C ). In addition, ECL cells obtained from CD16 + (after 10 days with CM) cultured in 3DBM systems, were able to form tube-like structures (Fig. 3B) . Tube-like structures were more stable over time when ECL were obtained from Mo treated with TF-rich supernatants (data not shown). Furthermore, when we studied VWF, VE-cadherin and eNOS as VEC markers, we observed that ECL cells exhibited homogenous VWF and VE-cadherin staining and distribution along tube-like structures ( Fig. 3C and D) . VWF and VE-cadherin appeared with a low diffuse pattern in CD16 + cultured with mECs-CM. However, eNOS was almost undetectable by immunocytochemistry (data not shown).
Transdifferentiation of CD16 + Mo into ECL cells was also assessed by analysis of VEC markers by flow cytometry. Initially the highly purified starting population of CD16 + Mo did not express VWF, eNOS, VE-Cadherin or VEGFR2 as VEC markers (data not shown), or CD34 as a marker for hematopoietic stem cells that was not detected initially or during the observation time (data not shown). After 8 days of culture in presence of mECs-CM, we observed increased expression of VEC markers in CD16 Mo, and these observations were more evident in the presence of high TF levels (Fig. 4) . To confirm that the observed effects were a result of TF and not other molecules such as CCL2 present in the medium, we cultured isolated Mo with rh-TF (100 pM) and rh-CCL2 (50 ng mL À1 ). We used also a supplemented culture medium with TNFa (10 lg mL À1 ), VEGF (100 lg mL
À1
) and bFGF (10 lg mL À1 ) as positive control for Mo transdifferentiation into ECL cells [7] . rh-CCL2 and positive control cultures showed ECL cells as single cells or clusters and sprouts of spindle-shaped cells (Fig. 5A) . A significantly higher amount of spindle cells was founded in TF supplemented cultures. Results show that rh-TF, also, induced VEC marker expression in ECL cells, and that expression was significantly higher than in ECL treated with rh-CCL2, positive controls or with CM from TF-silenced mECs (Fig. 5B ). Cells treated with CM of TF-silenced HMEC-1 presented less expression even than Mo treated with CM from scrambled HMEC-1 (4.05 AE 0.75 vs. 6.65 AE 1.35% for VE-cadherin, P < 0.01; 8.5 AE 1.75 vs. 22.35 AE 2.65% for VWF, P < 0.001; and 5.5 AE 1.25 vs. 1.35 AE 0.5% for eNOS). Moreover, immunocytochemistry showed that VWF expression (around 15% of the whole dishes) was only detected in ECL treated with rh-TF, whereas it was undetectable in rh-CCL2 or positive controls (Fig. 5C) .
In summary, these results indicate that Mo transdifferentiation into ECL cells is induced by TF released from microvascular endothelium.
Next, we examined whether ECL cells were recruited into the tube-like structures formed by mECs. Transdifferentiated ECL cells (Mo kept for 8 days in culture with the different CMs) were stained (living cell staining) and cultured with mECs in 3DBM for 24 h. ECL cells transdifferentiated by CM rich in TF variants showed enhanced recruitment into tube-like structures in comparison to those obtained from TF-silenced or empty vector mECs-CM (Fig. 6) .
To evaluate whether Mo proliferate during endothelial differentiation, the proliferative state was evaluated over time by the propidium iodide assay. The proportion of cells in phase S/G2 is higher on day 8 ( Figure S4 ), indicating that CM rich in TF variants also induce cell proliferation.
TF interacts with monocyte-b1 integrins to induce transdifferentiation into ECLs
Next, we explored whether TF-induced Mo transdifferentiation was mediated by b1-integrins. First, we demonstrated that b1-integrin transcript levels were upregulated approximately 3-and 4-fold, at day 5 and 8, respectively, by exposure to CM rich in TF variants (Fig. 7A) . We also used flow cytometry to examine whether TF increases cell surface b1-integrin expression. CM rich in TF variants induced an approximately 5-fold increase in b1-integrin cell surface expression, evident after 5 days in culture (control was CM obtained from empty vector transfected mECs) (Fig. 7B) . Moreover, there were no significant changes when Mo were treated with TFsilenced mECs conditioned media ( Figure S5A ). Interestingly, the TF-induced expression of b1-integrins kept increasing throughout the differentiation process, and was associated with the appearance of a new population of CD14 À cells (Fig. 7C ).
In addition, to directly analyze the role of b1-integrins in TF-induced Mo transdifferentiation, b1-integrins were blocked in Mo with a selective antibody and VEC markers were analyzed by flow cytometry after 8 days. Because a 5 b 1 is the main receptor for fibronectin, monocytes were placed on fibronectin-coated plates for 24 h and after pretreatment with 10 lg mL À1 of b1-integrin-blocking antibody (clone P5D2, Millipore) they were cultured with the different conditioned media enriched with flTF or asTF. b1-integrin blockade was proven by FACS analysis ( Figure S5B ). Figure 7(D) shows that when b1-integrins were blocked, TF was not able to induce VEC marker expression and, consequently, ECL transdifferentiation was abrogated. Unspecific IgG antibody was used as a control ( Figure S6 ). Finally, in order to verify whether TF interacts with b1-integrin, b1-integrin was immunoprecipitated from Mo lysates, applying anti-b1-integrin antibodies. Western blotting of the immunoprecipitates with anti-TF antibodies revealed an interaction between TF and b1-integrin ( Figure S7 ).
Discussion
Neovascularization is essential for tissue repair. Monocytes and macrophages have long been recognized as N = 6) . Statistical analysis was performed by ANOVA followed by the Tukey post-hoc test. ***P < 0.001 vs. day 2 in the same group, and ## P < 0.01 or ### P < 0.001 vs. Mo treated with mECs-CMon the same day. (B) Flow cytometric density plots of CD14 and b1-integrin expression at different time-points. (C) Graph shows the % of CD14 À /b1-integrin + corresponding to the new cell population that appears over time. Data are expressed as AE SEM (N = 6). Statistical analysis was performed by ANOVA followed by the Tukey post-hoc test. **P < 0.01 or ***P < 0.001 vs. day 2 in the same group, and ## P < 0.01 or We present evidence to suggest that this transdifferentiation process is likely to be mediated by TF/b1-integrin interaction. These findings indicate a novel angiogenic mechanism triggered by TF (flTF as well as asTF) to induce differentiation of Mo into ECL cells and thus promote angiogenesis.
Monocytes have pleiotropic functions. The recruitment of circulating blood monocytes into damaged tissue and the ensuing monocyte/macrophage angiogenic differentiation are critical to post-ischemic neovascularization and tissue repair. The ability of Mo to transdifferentiate into functional endothelium or ECL cells had already been shown [20, 21] ; however, there was no mechanistic understanding of the process. Numerous molecules have been considered angiogenic factors inducing Mo recruitment and ECL transdifferentiation. One of the more relevant was CCL2 [22, 23] . Previously, we have reported that TF in mECs induces cell signaling and CCL2 secretion to promote recruitment of smooth muscle cells to the periphery of endothelial cells and to stabilize mature new blood microvessels [15, 24] . However, our results show that CCL2 does not induce CD16 + /monocyte expansion or the expression of VEC markers in monocytes. Interestingly, Mo-secreted messengers such as Wnt5a can regulate TF expression in mECs [6] , and here we show that Mo not only induce TF expression but also secretion of two distinct TF variants, flTF (TFrich microvesicles) and asTF.
Mo are a heterogeneous cell population and it has been reported that Mo subsets possess distinct cell surface markers and functional characteristics relevant to their contribution to angiogenesis [25] . The identification of different angiogenic properties of Mo prompted several investigators to perform studies to delineate the functional significance of each subset. The CD16 + Mo subset is in low numbers in healthy individuals but increases after vascular injury and has a gene expression profile linked to angiogenesis [26] . There are conflicting studies regarding the cytokines that induce the differentiation of CD16 + Mo, with reports including IL-10 [19] , macrophage colony-stimulating factor (M-CSF) [27] , P-selectin [28] and CCL2 [29] . However, it is unknown how CD16 + Mo differentiation is induced in order to contribute to the angiogenic processes. We hypothesized, based on preliminary studies, that TF variants secreted by mECs could induce CD16 + Mo subset differentiation and exert a positive feedback between mECs and Mo to stimulate angiogenesis. Our results show that indeed TF secreted by mECs induces CD16 + Mo subset differentiation over time. When TF was knockdown in mECs, the conditioned media was not able to induce mobilization of Mo into CD16 + . On the contrary, high levels of TF variants in the conditioned media (obtained from TF overexpression in mECs) promoted a significant increase in CD16 + cells, suggesting a potent CD16 + differentiation effect of TF on Mo.
Although Mo plasticity seems to be restricted to conversion into tissue macrophages and dendritic cells, Mo can also acquire endothelial features [30] . Different studies have revealed that cultured Mo can develop an endothelial-like phenotype and form capillary-like tubes in vitro [7, 8] . Here, we show that TF secreted by mECs not only changes human Mo expression patterns but also upregulates VEC marker expression and the angiogenic properties. The Mo pro-angiogenic switch is mediated by TF/b1-integrin interaction. These findings are consistent with the reports that described that TF-rich microvesicles as well as asTF interact with ECs and Mo through b1-integrin [11, 13, 16] . Moreover, tumor cell-derived TNFa constitutes a microenvironmental signal that promotes differentiation of tumor-associated Mo towards a proangiogenic and pro-vasculogenic myeloid-endothelial phenotype via upregulation of the fibronectin receptor, integrin a5b1 [20] . In our study the increase of VEC markers in monocytes induced by TF is not related to cell pluripotency because Mo did not express CD34, a well-known marker for hematopoietic stem cells [31] . However, the ability to transdifferentiate to ECL cells seems to be associated to their proliferative state.
Interestingly, certain environmental conditions, such as tissue ischemia and necrosis, trigger the innate immune response and the infiltration of monocytes to the site of injury, resulting in cellular inflammation, tissue repair and vascular remodeling. However, factor(s) that regulated the transition from immune response to tissue repair were never described. We have shown that Mo can induce the expression and secretion of TF in angiogenic endothelial cells, and that the secreted TF variants interact with Mo in a paracrine fashion by upregulation of b1-integrin, inducing their transdifferentiation into functional ECL cells. Thus, induction of TF could trigger a phenotypic switch in innate immunity cells towards an angiogenic phenotype in the inflamed tissues, and these transdifferentiated cells form neovessels. These findings expand our understanding of the mechanisms governing inflammation-angiogenesis, and warrant further evaluation of TF isoforms as molecular switches that modulate angiogenesis. 
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